Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults Aged 50 to 84 Years

NCT04583618 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04583618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04583618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults Aged 50 to 84 Years
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
October 8, 2020
Completion date
January 20, 2022
Enrollment
750 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal immunization